Cardiac Rhythm Management Devices Market size to exceed $13.7bn by 2025

Cardiac Rhythm Management Devices Market size is set to exceed USD 13.7 billion by 2025; according to a new research report by Global Market Insights Inc.
 

Growing population with risk of sudden cardiac arrest and the recent technological advancements such as implanted cardioverter defibrillator over traditional pacemakers are one of the few factors that are boosting the cardiac rhythm management devices market growth positively. Rising demand for implantable cardioverter defibrillator devices in developing economies such as Asia Pacific, Latin America and Middle East is owing to increased prevalence of cardiovascular disorders. Several training workshops for surgeons and patients regarding the implantable cardioverter defibrillator devices are planned by various manufacturers that has further led to rise in the awareness amongst patients and surgeons. Hence, aforementioned factors are estimated to spur the cardiac rhythm management devices market growth in the near future.
 

Browse key industry insights spread across 500 pages with 910 market data tables & 7 figures & charts from the report, “Cardiac Rhythm Management Devices Market Size By Product (Pacemakers {Implantable Pacemakers, External Pacemakers}, Defibrillators (Implantable Cardioverter Defibrillator [ICDs], {Subcutaneous Implantable Cardioverter Defibrillator, Transvenous Implantable Cardioverter Defibrillator {Single-chamber ICDs, Dual-chamber ICDs}, External Defibrillator [ED] {Manual ED, Automated ED {Semi-automated External Defibrillator, Fully Automated External Defibrillator} Wearable Cardioverter Defibrillator, Cardiac Resynchronization Therapy Devices [CRTs] {CRT-D, CRT-P}Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Poland, Japan, China, India, Australia, South Korea, Taiwan, Brazil, Mexico, Argentina, Saudi Arabia, South Africa, UAE), Application Potential, Competitive Market Share & Forecast, 2019 – 2025 ” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/cardiac-rhythm-management-devices-market
 

Indian market is estimated to expand with 8.6% CAGR over the forecast period owing to rising prevalence of cardiovascular diseases and growing lifestyle changes in the country. According to recent research article, the prevalence of stroke and heart disease has increased by 50% from 1990 to 2016 in India with an increase witnessed in every state. Furthermore, growing prevalence of atrial fibrillation is one of the key factors boosting the market growth. According to a recently published article, about one-fifth of adults have multiple types of premature ventricular beats and around 1 million Indians are presently living with atrial fibrillation. Hence, the demand for cardiac rhythm management devices is growing among physicians with each passing day in order to cure arrhythmias and other cardiovascular disorders. Thus, such developments are expected to propel the India cardiac rhythm management devices market growth in the upcoming years.
 

Germany cardiac rhythm management devices market was valued at USD 974.1 million in 2018 and is projected to grow at lucrative rate over the forthcoming years. With rise in the prevalence of heart diseases, Germany ranked 8^th for higher rates of heart-related deaths among the Organization for Economic Co-operation (OECD) countries. According to the Max Plank Institute for Biology and Aging, over 310 people per 100,000 die in Germany each year owing to cardiovascular diseases. Furthermore, growing number of cardiac resynchronization therapy devices implanted in the country is one of the significant factors that is propelling the market growth positively. In addition, according to the European Society of Cardiology, in 2014, the number of cardiac resynchronization therapy devices implanted in the country were around 19,000. Hence, increase in number of cardiac rhythm management device implantations across the country will enhance the business growth in the future.
 

Some of the major key players in the global cardiac rhythm management devices market are are BIOTRONIK, ZOLL Medical, Boston Scientific, SCHILLER, Koninklijke Philips N.V., ABIOMED, Medtronic, Abbott, among other players. Key players are adopting various strategic initiatives such as partnerships, collaborations, merger & acquisition in order to expand their geographic presence and product portfolio. For instance, In March 2019, BIOTRONIK announced FDA approval of the Rivacor and Acticor high voltage cardiac rhythm management device families for the treatment of patients with cardiac arrhythmias.

 

Cardiac rhythm management devices market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million & volume in Units from 2014 to 2025, for the following segments:

Cardiac Rhythm Management Devices Industry, by Product, 2014 – 2025 (USD Million & Units)

• Pacemakers
  • Implantable Pacemakers
  • External Pacemakers
• Defibrillators
  • Implantable Cardioverter Defibrillator (ICD)
    • Subcutaneous Implantable Cardioverter Defibrillator     
    • Transvenous Implantable Cardioverter Defibrillator       
      • Single-chamber ICDs
      • Dual-chamber ICDs
  • External Defibrillator (ED)
    • Manual External Defibrillator        
    • Automated External Defibrillator
      • Semi-Automated External Defibrillator
      • Fully Automated External Defibrillator
    • Wearable Cardioverter Defibrillator
• Cardiac Resynchronization Therapy (CRT)
  • CRT-D
  • CRT-P

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Taiwan
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia  
  • UAE